IRB Review of Social Media Recruitment and Retention Programs
Explore how existing regulations can establish best practices in using social media for clinical research participant recruitment.
Improving Access to Research for Diverse and Underserved Populations
Increasing diversity and inclusion in research has long been a challenge in the clinical research community. Learn strategies to increase access to clinical trials for all.
Q&A – The New Urgency of Clinical Trials: How Oncology Leads the Evolution
How has the COVID-19 pandemic changed oncology research--and research in general? Read more for the follow-up blog to our recent symposium:
Q&A – Site and Patient Engagement
CEO Gadi Saarony and Deb Tatton, Parexel Senior VP of Global Clinical Operations, discuss site and patient engagement. Read more:
Q&A – The New Normal: Considerations for Restarting Research
Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:
Patient Engagement and the IRB
With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?
Making Sense of the New HUD Guidance
Understand how the new HUD guidance clarifies responsibilites of the IRB and institutions, while widening the access of small communities to HUDs.
Should Social Media Be Part of Your Research Toolbox?
Social media has emerged as a valuable tool for diverse stakeholders across the research community. Learn about the risks and benefits in this article.